Company Announcements

Scapa Group Directorate Change

Source: RNS
RNS Number : 4239E
Scapa Group PLC
28 February 2020


28  February 2020


LEI No. 213800QIPVTK5ES5UU36



Scapa Group plc ("Scapa" or "the Group")


Directorate change


Scapa Group plc (AIM: SCPA) announces that Pierre Guyot, Non-Executive Director of the Company, has notified the Board of his intention to resign as a director, with effect from 29 February 2020, for personal reasons.  


The Board shall commence a search for a replacement Non-Executive Director.



Larry Pentz, Scapa's Chairman, said:


"On behalf of the Board, I would like to thank Pierre for the contribution he has made during his time on the Board.  We wish him well for the future."




For further information:


Scapa Group plc

Heejae Chae - Group Chief Executive


Tel: 0161 301 7430


Numis Securities Limited

(Nominated Adviser/Joint Broker)


Mark Lander, Freddie Barnfield

Tel: 020 7260 1000


(Joint Broker)


Chris Bowman, Toby Flaux


Tel: 020 3207 7800

FTI Consulting

(Media Relations)


Simon Conway, Victoria Foster Mitchell

Tel: 020 3727 1000


About Scapa Group plc

Scapa Group plc is a diversified Healthcare and Industrial company focused on bringing best-in-class innovation, design and manufacturing solutions to its customers.



Scapa Healthcare is the trusted strategic partner of choice for the world's leading companies in Advanced Wound Care, Consumer Wellness and Medical Device Fixation. We partner with the top global MedTech companies to develop and manufacture innovative skin friendly medical device fixation and topical solutions, from inception through to market delivery, from our state-of-the-art facilities.


For further information, please visit



Scapa Industrial is a global supplier of bonding solutions and manufacturer of adhesive-based products which offer meaningful value in industrial applications due to their lightweight, easy-to-apply properties. We are recognised for our unparalleled range of products, including adhesive tapes, films and foams, and we can engineer custom designs for even the most unique applications.


For further information, please visit


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit